Anavex Announces Positive Primary and Secondary Endpoints were Achieved in a Phase 2a Clinical Trial of ANAVEX 2-73 in Alzheimer’s Disease November 9, 2015
Anavex to Present Interim Phase 2a Clinical Trial Data of ANAVEX 2-73 at Late-Breaking Oral Session of CTAD 2015 Conference October 7, 2015
Anavex Completes Patient Enrollment for Phase 2a Alzheimer’s Trial Ahead of Schedule September 28, 2015